Caladrius Biosciences Inc CLBS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:17 AM EDT
0.5325quote price arrow down-0.0006 (-0.1125%)
Volume
34,928
52 week range
0.40 - 1.62
Loading...
  • Open0.525
  • Day High0.54
  • Day Low0.525
  • Prev Close0.5331
  • 52 Week High1.62
  • 52 Week High Date06/30/21
  • 52 Week Low0.40
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap32.23M
  • Shares Out60.52M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change-36.73

KEY STATS

  • Open0.525
  • Day High0.54
  • Day Low0.525
  • Prev Close0.5331
  • 52 Week High1.62
  • 52 Week High Date06/30/21
  • 52 Week Low0.40
  • 52 Week Low Date05/12/22
  • Market Cap32.23M
  • Shares Out60.52M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change-36.73

RATIOS/PROFITABILITY

  • EPS (TTM)-0.40
  • P/E (TTM)-1.35
  • Fwd P/E (NTM)-1.76
  • EBITDA (TTM)-27.538M
  • ROE (TTM)-23.78%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)9.15%
  • Net Margin (TTM)-179.78%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Caladrius Biosciences Inc

There is no recent news for this security.

Profile

MORE
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of cell therapies designed to reverse disease and promote the regeneration of damaged tissue. The Company is developing therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. The Company’s product candidates include CLBS16, CLBS12 and CLBS201. The CLBS16...
Gregory Brown M.D.
Independent Chairman of the Board
David Mazzo Ph.D.
President, Chief Executive Officer, Director
William Sietsema
Vice President - Global Regulatory Affairs
Address
110 Allen Road, Second Floor
Basking Ridge, NJ
07920
United States

Top Peers

SYMBOLLASTCHG%CHG
SYN
Synthetic Biologics Inc
0.1978-0.0084-4.0737%
TNXP
Tonix Pharmaceuticals Holding Corp
1.58-0.08-4.79%
ONCS
OncoSec Medical Inc
0.794-0.018-2.2167%
FWP
Forward Pharma A/S
4.50+0.03+0.67%
NBSE
NeuBase Therapeutics Inc
0.9277-0.0071-0.7595%